GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Xinguang Pharmaceutical Co Ltd (SZSE:300519) » Definitions » Net Income Including Noncontrolling Interests

Zhejiang Xinguang Pharmaceutical Co (SZSE:300519) Net Income Including Noncontrolling Interests : ¥43.4 Mil (TTM As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Zhejiang Xinguang Pharmaceutical Co Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Zhejiang Xinguang Pharmaceutical Co's Net Income Including Noncontrolling Interests for the three months ended in Sep. 2024 was ¥12.3 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Sep. 2024 was ¥43.4 Mil.


Zhejiang Xinguang Pharmaceutical Co Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Zhejiang Xinguang Pharmaceutical Co's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Xinguang Pharmaceutical Co Net Income Including Noncontrolling Interests Chart

Zhejiang Xinguang Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Income Including Noncontrolling Interests
Get a 7-Day Free Trial Premium Member Only Premium Member Only 93.90 98.98 114.28 108.82 64.36

Zhejiang Xinguang Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.16 5.66 22.83 2.68 12.28

Zhejiang Xinguang Pharmaceutical Co Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥43.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhejiang Xinguang Pharmaceutical Co Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Zhejiang Xinguang Pharmaceutical Co's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Xinguang Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No.25, Huancheng West Road, Zhejiang Province, Shengzhou, CHN, 312400
Zhejiang Xinguang Pharmaceutical Co Ltd engages in the production and operation of pharmaceuticals. Its products cover cardiovascular series, digestive system, respiratory system series, orthopedics series, health food series, urinary system series, tonic series, and remove heat and toxic substance. It produces an oral solution, tablets, capsules, granules, powders and syrup drugs.

Zhejiang Xinguang Pharmaceutical Co Headlines

No Headlines